Synthesis, characterization and evaluation of novel benzothiazole clubbed chromene derivatives for their anti-inflammatory potential

References

• Kidd, B. L.; Urban, L. A. Mechanisms of Inflammatory Pain. Br. J. Anaesth 2001, 87, 3–11. https://doi.org/10.1093/bja/87.1.3
   PubMed Web of Science ®Google Scholar
• Rosenfeld, M. E. Inflammation and Atherosclerosis: direct versus Indirect Mechanisms. Curr. Opin. Pharmacol 2013, 13, 154–160. DOI: 10.1016/j.coph.2013.01.003
   PubMed Web of Science ®Google Scholar
• Donath, M. Y. Targeting Inflammation in the Treatment of Type 2 Diabetes: time to Start. Nat. Rev. Drug Discov. 2014, 13, 465–476. DOI: 10.1038/nrd4275
   PubMed Web of Science ®Google Scholar
• Walsh, D. A.; McWilliams, D. F. Mechanisms, Impact and Management of Pain in Rheumatoid Arthritis. Nat. Rev. Rheumatol. 2014, 10, 581–592. DOI: 10.1038/nrrheum.2014.64
   PubMed Web of Science ®Google Scholar
• Akdis, C. A. Therapies for Allergic Inflammation: refining Strategies to Induce Tolerance. Nat. Med. 2012, 18, 736–749. DOI: 10.1038/nm.2754
   PubMed Web of Science ®Google Scholar
• Rodrigues, E. B.; Farah, M. E.; Bottós, J. M.; Bom Aggio, F. Nonsteroidal anti-Inflammatory Drugs in the Treatment of Retinal Diseases. Dev. Ophthalmol. 2016, 55, 212–220. DOI: 10.1159/000431197
   PubMedGoogle Scholar
• Meek, I. L.; van de Laar, M. A. F. J.; Vonkeman, H. E. Non-Steroidal anti-Inflammatory Drugs: An Overview of Cardiovascular Risks. Pharmaceuticals 2010, 3, 2146–2162. DOI: 10.3390/ph3072146
   Google Scholar
• Simmons, D. L.; Westover, D. W. K. Nonsteroidal anti-Inflammatory Drugs, Acetaminophen, Cyclooxygenase 2, and Fever. Clin. Infect. Dis 2000, 31, S211–S218. DOI:10.3390/ph3072146
   PubMed Web of Science ®Google Scholar
• Musumba, C.; Pritchard, D. M.; Pirmohamed, M. Review Article: cellular and Molecular Mechanisms of NSAID-Induced Peptic Ulcers. Aliment. Pharmacol. Ther 2009, 30, 517–531. https://doi.org/10.1111/j.1365-2036.2009.04086.x
   PubMed Web of Science ®Google Scholar
• Cannon, C. P.; Cannon, P. J. Physiology. COX-2 Inhibitors and Cardiovascular Risk. Science 2012, 336, 1386–1387. doi: 10.1126/science.1224398
   PubMed Web of Science ®Google Scholar
• Bao, H.; Ge, Y.; Zhuang, S.; Dworkin, L. D.; Liu, Z.; Gong, R. Inhibition of Glycogen Synthase Kinase 3β Prevents NSAID-Induced Acute Kidney Injury. Kidney Int 2012, 81, 662–673. DOI: 10.1038/ki.2011.443
   PubMed Web of Science ®Google Scholar
• Aithal, G. P. Hepatotoxicity Related to Antirheumatic Drugs. Nat. Rev. Rheumatol. 2011, 7, 139–150. DOI: 10.1038/nrrheum.2010.214
   PubMed Web of Science ®Google Scholar
• Pratap, R.; Ram, V. J. Natural and Synthetic Chromenes, Fused Chromenes, and Versatility of Dihydrobenzo[h]Chromenes in Organic Synthesis. Chem. Rev. 2014, 114, 10476–10526. DOI: 10.1021/cr500075s
   PubMed Web of Science ®Google Scholar
• Anderson, D. R.; Hegde, S.; Reinhard, E.; Gomez, L.; Vernier, W. F.; Lee, L.; Liu, S.; Sambandam, A.; Snider, P. A.; Masih, L. Aminocyanopyridine Inhibitors of Mitogen Activated Protein Kinase-Activated Protein Kinase 2 (MK-2). Bioorg. Med. Chem. Lett 2005, 15, 1587–1590. https://doi.org/10.1016/j.bmcl.2005.01.067
   PubMed Web of Science ®Google Scholar
• Gourdeau, H.; Leblond, L.; Hamelin, B.; Desputeau, C.; Dong, K.; Kianicka, I.; Custeau, D.; Boudreau, C.; Geerts, L.; Cai, S.-X.; et al. Antivascular and Antitumor Evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents. Mol. Cancer Ther. 2004, 3, 1375–1384.,
   PubMed Web of Science ®Google Scholar
• Cheng, J. F.; Ishikawa, A.; Ono, Y.; Arrhenius, T.; Nadzan, A. Novel Chromene Derivatives as TNF-α Inhibitors. Bioorg. Med. Chem. Lett 2003, 13, 3647–3650. https://doi.org/10.1016/j.bmcl.2003.08.025
   PubMed Web of Science ®Google Scholar
• Thareja, S.; Verma, A.; Kalra, A.; Gosain, S.; Rewatkar, P. V.; Kokil, G. R. Novel Chromeneimidazole Derivatives as Antifungal Compounds: synthesis and in Vitro Evaluation. Acta. Pol. Pharm 2010, 67, 423–427. PMID 20635539
   PubMed Web of Science ®Google Scholar
• Riveiro, M. E.; De Kimpe, N.; Moglioni, A.; Vazquez, R.; Monczor, F.; Shayo, C.; Davio, C. Coumarins: old Compounds with Novel Promising Therapeutic Perspectives. Cmc. 2010, 17, 1325–1338. DOI: 10.2174/092986710790936284
   PubMed Web of Science ®Google Scholar
• Jain, N.; Xu, J.; Kanojia, R. M.; Du, F.; Jian-Zhong, G.; Pacia, E.; Lai, M.-T.; Musto, A.; Allan, G.; Reuman, M.; et al. Identification and Structure − Activity Relationships of Chromene-Derived Selective Estrogen Receptor Modulators for Treatment of Postmenopausal Symptoms. J. Med. Chem. 2009, 52, 7544–7569. DOI | 10.1021/jm900146e
   PubMed Web of Science ®Google Scholar
• Mori, J.; Iwashima, M.; Takeuchi, M.; Saito, H. A. Synthetic Study on Antiviral and Antioxidative Chromene Derivative. Chem. Pharm. Bull. 2006, 54, 391–396. https://doi.org/10.1248/cpb.54.391
   PubMed Web of Science ®Google Scholar
• Tripathi, R. P.; Tripathi, R.; Bhaduri, A. P.; Singh, S. N.; Chatterjee, R. K.; Murthy, P. K. Antifilarial Activity of Some 2H-1-Benzopyran-2-Ones (Coumarins). Acta. Tropica 2000, 76, 101–106. https://doi.org/10.1016/S0001-706X(00)00070-X
   PubMed Web of Science ®Google Scholar
• Ough, M.; Lewis, A.; Bey, E. A.; Gao, J.; Ritchie, J. M.; Bornmann, W.; Boothman, D. A.; Oberley, L. W.; Cullen, J. J. Efficacy of Beta-Lapachone in Pancreatic Cancer Treatment: exploiting the Novel, Therapeutic Target NQO1. Cancer. Biol. Ther 2005, 4, 102–102. DOI: 10.4161/cbt.4.1.1382
   Web of Science ®Google Scholar
• Moon, D. O.; Choi, Y. H.; Kim, N. D.; Park, Y. M.; Kim, G. Y. Anti-Inflammatory Effects of Beta-Lapachone in Lipopolysaccharide-Stimulated BV2 Microglia. Int. Immunopharmacol 2007, 7, 506–514. DOI: 10.1016/j.intimp.2006.12.006
   PubMed Web of Science ®Google Scholar
• Elisa, P. S.; Ana, E. B.; Ravelo, A. G.; Yapu, D. J.; Turba, A. G. Antiplasmodial Activity of Naphthoquinones Related to Lapachol and β-Lapachone. Chem. Biodivers 2005, 2, 264–274. DOI: 10.1002/cbdv.200590009
   PubMed Web of Science ®Google Scholar
• Bhat, M. A.; Siddiqui, N.; Khan, S. A. Synthesis of Novel 3-(4-Acetyl- 5H/Methyl-5-Substituted Phenyl-4,5-Dihydro-1,3,4-Oxadiazol-2-Yl)-2H-Chromen-2-Ones as Potential Anticonvulsant Agents. Acta. Pol. Pharm 2008, 65, 235–239. PMID:18666431
   PubMed Web of Science ®Google Scholar
• Huang, S. T.; Hsei, I. J.; Chen, C. Synthesis and Anticancer Evaluation of Bis(-Benzimidazoles), Bis(Benzoxazoles), and Benzothiazoles. Bioorg. Med. Chem 2006, 14, 6106–6119. https://doi.org/10.1016/j.bmc.2006.05.007
   PubMed Web of Science ®Google Scholar
• Patel, N. B.; Shaikh, F. M. Synthesis and Antimicrobial Activity of New 4-Thiazolidinone Derivatives Containing 2-Amino-6-Methoxybenzothiazole. Saudi Pharm. J 2010, 18, 129–136. https://doi.org/10.1016/j.jsps.2010.05.002
   PubMedGoogle Scholar
• Siddiqui, N.; Rana, A.; Khan, S. A.; Haque, S. E.; Alam, M. S.; Ahsan, W.; Ahmed, S. Synthesis of 8-Substituted-4-(2/4-Substituted Phenyl)-2H-[1,3,5]Triazino[2,1-b][1,3]Benzothiazole-2-Thiones and Their Anticonvulsant, anti-Nociceptive, and Toxicity Evaluation in Mice. J. Enz. Inhib. Med. Chem 2009, 24, 1344–1350. DOI: 10.3109/14756360902888176
   PubMed Web of Science ®Google Scholar
• Yogeeswari, P.; Sriram, D.; Mehta, S.; Nigam, D.; Kumar, M. M.; Murugesan, S.; Stables, J. P. Anticonvulsant and Neurotoxicity Evaluation of Some 6-Substituted Benzothiazolyl-2-Thiosemicarbazones. IL Farmaco. 2005, 60, 1–5. DOI: 10.1016/j.farmac.2004.09.001
   PubMedGoogle Scholar
• Van Zandt, M. C.; Jones, M. L.; Gunn, D. E.; Geraci, L. S.; Jones, J. H.; Sawicki, D. R.; Sredy, J.; Jacot, J. L.; DiCioccio, A. T.; Petrova, T.; et al. Discovery of 3-[(4,5,7-Trifluorobenzothiazol-2-Yl)Methyl]Indole-N-Acetic Acid (Lidorestat) and Congeners as Highly Potent and Selective Inhibitors of Aldose Reductase for Treatment of Chronic Diabetic Complications. J. Med. Chem. 2005, 48, 3141–3152.,. DOI:10.1021/jm0492094
   PubMed Web of Science ®Google Scholar
• Nagarajan, S. R.; De Crescenzo, G. A.; Getman, D. P.; Lu, H.-F.; Sikorski, J. A.; Walker, J. L.; McDonald, J. J.; Houseman, K. A.; Kocan, G. P.; Kishore, N.; et al. Discovery of Novel Benzothiazolesulfonamides as Potent Inhibitors of HIV-1 Protease. Bioorg. Med. Chem 2003, 11, 4769–4777. https://doi.org/10.1016/j.bmc.2003.07.001
   PubMed Web of Science ®Google Scholar
• Takasu, K.; Inoue, H.; Kim, H.; Suzuki, M.; Shishido, T.; Wataya, Y.; Ihara, M. Rhodacyanine Dyes as Antimalarials. 1. Preliminary Evaluation of Their Activity and Toxicity. J. Med. Chem. 2002, 45, 995–998. DOI: 10.1021/jm0155704
   PubMed Web of Science ®Google Scholar
• Munirajasekhar, D.; Himaja, M.; Mali, S. V. A Facile and Efficient Synthesis of 2-(5-(4-Substitutedphenyl)-4,5-Dihydro-3-Phenylpyrazol-1-Yl)-6-Substituted Benzo Thiazoles and Their Biological Studies. J. Heterocyclic Chem. 2014, 51, 459–465. DOI: 10.1002/jhet.1618
   Web of Science ®Google Scholar
• Patel, R. V.; Park, S. W. Catalytic N-Formylation for Synthesis of 6-Substituted-2-Benzothiazolylimino-5-Piperazinyl-4-Thiazolidinone Antimicrobial Agents. Res. Chem. Intermed. 2015, 41, 5599–5609. https://doi.org/10.1007/s11164-014-1684-8
   Web of Science ®Google Scholar
• Oketani, K.; Nagakura, N.; Harada, K.; Inoue, T. In Vitro Effects of E3040, a Dual Inhibitor of 5-Lipoxygenase and Thromboxane A2 Synthetase, on Eicosanoid Production. Eur. J. Pharmacol 2001, 422, 209–216. https://doi.org/10.1016/S0014-2999(01)01022-6
   PubMed Web of Science ®Google Scholar
• Florence, D.; Antonio, A.; Carole, D. G.; Maxime, R.; Erik, D. C.; Pierre, T.; Jean-Pierre, G. Synthesis and Antileishmanial Activity of (1,3-Benzothiazol-2-Yl) Amino-9-(10H)-Acridinone Derivatives. Eur. J. Med. Chem 2004, 39, 685–690. DOI: 10.1016/j.ejmech.2004.04.006
   PubMed Web of Science ®Google Scholar
• Koci, J.; Klimesova, V.; Waisser, K.; Kaustova, J.; Dahse, H. M.; Mollmann, U. Heterocyclic Benzazole Derivatives with Antimycobacterial in Vitro Activity. Bioorg. Med. Chem. Lett 2002, 12, 3275–3278.https://doi.org/10.1016/S0960-894X(02)00697-2
   PubMed Web of Science ®Google Scholar
• Wen, L. R.; Xie, H. Y.; Li, M. A Basic Ionic Liquid Catalyzed Reaction of Benzothiazole, Aldehydes, and 5,5-Dimethyl-1,3-Cyclohexanedione: Efficient Synthesis of Tetrahydrobenzo[b]Pyrans. J. Heterocyclic Chem. 2009, 46, 954–959. https://doi.org/10.1002/jhet.183
   Web of Science ®Google Scholar
• Stepanchikova, A. V.; Lagunin, A. A.; Filimonov, D. A.; Poroikov, V. V. Prediction of Biological Activity Spectra for Substances: evaluation on the Diverse Sets of Drug-like Structures. Cmc. 2003, 10, 225–233. DOI: 10.2174/0929867033368510
   PubMed Web of Science ®Google Scholar
• Anzali, S.; Barnickel, G.; Cezanne, B.; Krug, M.; Filimonov, D.; Poroikov, V. Discriminating between Drugs and Nondrugs by Prediction of Activity Spectra for Substances (PASS). J. Med. Chem. 2001, 44, 2432–2437. DOI: 10.1021/jm0010670
   PubMed Web of Science ®Google Scholar
• Winter, C. A.; Risley, E. A.; Nuss, G. W. Carageenan-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs. Proc. Soc. Exp. Biol. Med 1962, 111, 544–547. https://doi.org/10.3181/00379727-111-27849
   PubMed Web of Science ®Google Scholar